J Shipley

Author PubWeight™ 80.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? Br J Cancer 2001 3.23
2 Isolation of human chromosome 13-specific DNA sequences cloned from flow sorted chromosomes and potentially linked to the retinoblastoma locus. Cancer Genet Cytogenet 1984 3.17
3 Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994 3.10
4 The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 1996 2.45
5 Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 1997 2.32
6 Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 1995 2.14
7 Core services and cardiac surgery. N Z Med J 1995 2.04
8 Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br J Cancer 2005 1.46
9 Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer 1999 1.42
10 Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol 2001 1.38
11 PTEN mutations are uncommon in Proteus syndrome. J Med Genet 2001 1.35
12 Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon. Blood 1996 1.34
13 Novel formation and amplification of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 1996 1.29
14 PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells. Br J Cancer 2003 1.28
15 Differential amplification, assembly, and relocation of multiple DNA sequences in human neuroblastomas and neuroblastoma cell lines. Proc Natl Acad Sci U S A 1985 1.23
16 Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res 1996 1.23
17 Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change. Br J Cancer 1998 1.18
18 Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma. Oncogene 2010 1.17
19 Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group Study. Med Pediatr Oncol 2001 1.17
20 Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. Oncogene 1996 1.17
21 MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer 2010 1.16
22 TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. Br J Cancer 2008 1.13
23 The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies. Hum Mol Genet 1997 1.13
24 A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 2000 1.11
25 Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. Br J Cancer 2002 1.08
26 Disruption of imprinted genes at chromosome region 11p15.5 in paediatric rhabdomyosarcoma. Neoplasia 1999 1.06
27 ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5. Neoplasia 1999 1.06
28 Comparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expression. Proc Natl Acad Sci U S A 2001 1.03
29 Chromosomal imbalances in familial chronic lymphocytic leukaemia: a comparative genomic hybridisation analysis. Leukemia 2002 1.02
30 KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature. Int J Androl 2007 1.02
31 Primitive neuroectodermal tumor of the kidney confirmed by fluorescence in situ hybridization. Am J Surg Pathol 1997 1.01
32 Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosomes Cancer 2000 1.00
33 Stem cell factor as a novel diagnostic marker for early malignant germ cells. J Pathol 2008 1.00
34 Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents. J Pathol 2009 1.00
35 Phyllodes tumors of the breast analyzed by comparative genomic hybridization and association of increased 1q copy number with stromal overgrowth and recurrence. Genes Chromosomes Cancer 1997 0.99
36 Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk. Oncogene 1997 0.98
37 Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic features. Am J Surg Pathol 1999 0.98
38 Pez: a novel human cDNA encoding protein tyrosine phosphatase- and ezrin-like domains. Biochem Biophys Res Commun 1995 0.97
39 Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer 2001 0.97
40 Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults. Br J Cancer 2001 0.91
41 Establishing germ cell origin of undifferentiated tumors by identifying gain of 12p material using comparative genomic hybridization analysis of paraffin-embedded samples. Diagn Mol Pathol 1998 0.90
42 The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP. Hum Mol Genet 1998 0.89
43 Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers. Br J Cancer 2006 0.87
44 Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: a replication and extension. Am J Psychiatry 1998 0.87
45 Disruption of the ATM gene in breast cancer. Cancer Genet Cytogenet 2001 0.86
46 Cloning and mapping of members of the MYM family. Genomics 1999 0.86
47 Evaluation of 24-color multifluor-fluorescence in-situ hybridization (M-FISH) karyotyping by comparison with reverse chromosome painting of the human breast cancer cell line T-47D. Chromosome Res 2000 0.85
48 Dual colour fluorescence in situ hybridization to paraffin-embedded samples to deduce the presence of the der(X)t(X;18)(p11.2;q11.2) and involvement of either the SSX1 or SSX2 gene: a diagnostic and prognostic aid for synovial sarcoma. J Pathol 1999 0.85
49 Genomic copy number and expression patterns in testicular germ cell tumours. Br J Cancer 2007 0.85
50 Gain of 1q25-32, 12q23-24.3, and 17q12-22 facilitates tumorigenesis and progression of human squamous cell lung cancer. J Pathol 2006 0.84
51 Definition of chromosome aberrations in testicular germ cell tumor cell lines by 24-color karyotyping and complementary molecular cytogenetic analyses. Cancer Genet Cytogenet 2001 0.83
52 Genomic gain and over expression of CCL2 correlate with vascular invasion in stage I non-seminomatous testicular germ-cell tumours. Int J Androl 2011 0.83
53 Mitomycin C induced chromosome damage in fetal blood cultures and prenatal diagnosis of Fanconi's anaemia. Prenat Diagn 1984 0.83
54 Rhabdomyosarcoma subtyping by immunohistochemical assessment of myogenin: tissue array study and review of the literature. Pathol Oncol Res 2008 0.83
55 Experimental pathology and breast cancer genetics: new technologies. Recent Results Cancer Res 1998 0.83
56 Molecular and cytologic analysis of DNA amplification in retinoblastoma. Cancer Genet Cytogenet 1985 0.82
57 Chromosome translocations in sarcomas and the analysis of paraffin-embedded material. J Pathol 1998 0.82
58 Molecular cytogenetic analysis consistently identifies translocations involving chromosomes 1, 2 and 15 in five embryonal rhabdomyosarcoma cell lines and a PAX-FOXO1A fusion gene negative alveolar rhabdomyosarcoma cell line. Cytogenet Cell Genet 2001 0.81
59 Expression of cysteine proteases in extraembryonic tissues during mouse embryogenesis. Arch Biochem Biophys 1999 0.81
60 Common variants identified in genome-wide association studies of testicular germ cell tumour: an update, biological insights and clinical application. Andrology 2015 0.80
61 Distinct genetic and epigenetic changes in medullary breast cancer. Int J Surg Pathol 2003 0.80
62 Inappropriate electrical countershocks by an automated external defibrillator. Ann Emerg Med 1992 0.80
63 Chromosome 3 imbalances are the most frequent aberration found in non-small cell lung carcinoma. Lung Cancer 1999 0.79
64 A novel and rapid method for isolating sequences adjacent to rare cutting sites and their use in physical mapping. Nucleic Acids Res 1991 0.78
65 Synovial sarcoma specific translocation associated with both epithelial and spindle cell components. Int J Cancer 1999 0.78
66 Molecular analysis of simple variant translocations in acute promyelocytic leukemia. Genes Chromosomes Cancer 1994 0.78
67 Dramatic response of malignant craniopharyngioma to cis-platin-based chemotherapy. Should craniopharyngioma be considered as a suprasellar 'germ cell' tumour? Br J Neurosurg 2004 0.78
68 ICAAR, a novel member of a new family of transmembrane, tyrosine phosphatase-like proteins. Biochem Biophys Res Commun 1996 0.78
69 Failure to normalize the dexamethasone suppression test: association with length of illness. Biol Psychiatry 1985 0.77
70 Predictive power of an in vitro system to assess drug interactions of an antimuscarinic medication: a comparison of in vitro and in vivo drug-drug interaction studies of trospium chloride with digoxin. J Clin Pharmacol 2006 0.77
71 Long-term intrathecal ziconotide therapy: a case study and discussion. Neuromodulation 2001 0.77
72 Identification of region-specific yeast artificial chromosomes using pools of Alu element-mediated polymerase chain reaction probes labeled via linear amplification. Genomics 1992 0.76
73 Molecular characterisation of the t(1;15)(p22;q22) translocation in the prostate cancer cell line LNCaP. Cytogenet Genome Res 2006 0.76
74 No evidence for V600E BRAF mutation in the seminoma cell line TCam-2. Genes Chromosomes Cancer 2010 0.75
75 Recent advances in the diagnosis, prognosis and classification of childhood solid tumours. Br Med Bull 1996 0.75
76 Scanning laser Doppler imaging may predict disease progression of localized scleroderma in children and young adults. Br J Dermatol 2013 0.75
77 AHEC students "try on" rural practice. Mo Med 1998 0.75
78 Novel DNA rearrangement phenomena associated with DNA amplification in human neuroblastomas and neuroblastoma cell lines. Prog Clin Biol Res 1986 0.75
79 Main political parties' health policies. N Z Health Hospital 1996 0.75
80 Performance on the visual cliff by cats with marginal gyrus lesions. J Comp Physiol Psychol 1976 0.75
81 Characterization of a t(8;13)(p11;q11-12) in an atypical myeloproliferative disorder. Genes Chromosomes Cancer 1998 0.75
82 Application of molecular genetics and cytogenetics to breast cancer and soft tissue sarcomas. Ann Oncol 1994 0.75
83 Correspondence between effects of 5-azacytidine on SCE formation, cell cycling and DNA methylation in Chinese hamster cells. Mutat Res 1985 0.75
84 Fluorescence itIn Situ Hybridization. Methods Mol Med 2001 0.75
85 How Minister sees health service future. N Z Health Hospital 1994 0.75